文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

2012-2020年麻疹和风疹全球战略计划中期审查报告:背景与摘要

Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
PubMed 文献 · Vaccine · 2018-01-01

2012年麻疹和风疹倡议发布《2012-2020年全球麻疹和风疹战略计划》,旨在通过五项核心策略在至少五个WHO区域消除麻疹和风疹。截至2015年底未达任何里程碑,WHO免疫战略咨询专家组建议中期审查。审查团队认为消除麻疹取得显著进展但进展放缓,策略合理但实施受国家自主性和政治意愿不足制约。

要点

  • 2015年全球估计有134,200例麻疹死亡,2010年估计有超过10万例先天性风疹综合征婴儿出生。
  • 所有六个WHO区域设定了2020年消除麻疹目标,两个区域设定了2020年消除风疹目标,但世界卫生大会尚未批准全球根除目标。
  • 审查团队建议各国继续努力实现消除目标,重点加强现有免疫系统;策略合理但实施受国家自主性和资源不足阻碍。

核心结论

  • 消除麻疹已取得显著进展但进展放缓;《计划》阐述的策略是合理的,但全面实施受到国家自主性和全球政治意愿不足的阻碍,反映为资源不足。
  • 审查团队建议各国继续努力实现消除目标,重点加强现有免疫系统。

研究设计与样本

  • 由五名成员组成的团队审查文件并对利益相关方进行访谈,作为审查结论和建议的基础。

主要发现

  • 2015年全球估计发生134,200例麻疹死亡。
  • 2010年全球估计有超过100,000名婴儿出生时患有先天性风疹综合征。
  • 截至2015年底,《计划》的2015年里程碑均未实现。
  • 所有六个WHO区域设定了2020年消除麻疹目标,两个区域设定了2020年消除风疹目标。
  • 世界卫生大会尚未批准麻疹或风疹的全球根除目标。

关键数值与推荐

  • 《计划》旨在通过实施五项核心策略,到2020年底在至少五个WHO区域实现麻疹和风疹消除,并以2015年里程碑评估进展。
  • WHO免疫战略咨询专家组建议对《计划》进行中期审查,以评估目标进展、评估策略实施质量并总结经验教训。
  • 审查报告详细列出了针对《计划》五项策略以及脊灰过渡、治理和资源动员领域的建议。

临床怎么用

  • 审查团队建议各国继续努力实现消除目标,重点加强现有免疫系统。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measles, a vaccine-preventable illness, is one of the most infectious diseases known to man. In 2015, an estimated 134,200 measles deaths occurred globally. Rubella, also vaccine-preventable, is a concern because infection during pregnancy can result in congenital defects in the baby. More than 100,000 babies with congenital rubella syndrome were estimated to have been born globally in 2010. Eradication of both measles and rubella is considered to be feasible, beneficial, and more cost-effective than high-level control. All six World Health Organization (WHO) regions have measles elimination goals by 2020 and two have rubella elimination goals by that year. However, the World Health Assembly has not endorsed a global eradication goal for either disease. In 2012, the Measles and Rubella Initiative published a Global Measles and Rubella Strategic Plan, 2012-2020, referred to hereafter as the Plan, which aimed to achieve measles and rubella elimination in at least five WHO regions by end-2020 through the implementation of five core strategies, with progress evaluated against 2015 milestones. When, by end-2015, none of these milestones had been met, WHO's Strategic Advisory Group of Experts on Immunization (SAGE) recommended a mid-term review of the Plan to evaluate progress toward goals, assess the quality of strategy implementation, and formulate lessons learned. A five-member team reviewed documents and conducted interviews with stakeholders as the basis for the review's conclusions and recommendations. This team concluded that, although significant progress in measles elimination had been made, progress had slowed. It recommended that countries continue to work toward elimination goals with a focus on strengthening ongoing immunization systems. In addition, it concluded that the strategies articulated in the Plan were sound, however full implementation had been impeded by inadequate country ownership and global political will, reflected in inadequate resources. Detailed recommendations for each of the Plan's five strategies as well as the areas of polio transition, governance and resource mobilization are outlined.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Orenstein WA, Cairns L, Hinman A, et al. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary. Vaccine. 2018. PMID: 29307368. doi:10.1016/j.vaccine.2017.10.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。